Table 1.
Comparison of characteristics between survivors and non-survivor inpatients with COVID-19: the COCORICO study
| Characteristics | Total | Survivors | Non-survivors | p |
|---|---|---|---|---|
| (n = 255) | (n = 190) | (n = 65) | ||
| Demographic characteristic, n (%) | ||||
| Male sex | 141 (55.3) | 96 (50.8) | 45 (68.2) | 0.01 |
| Age class (y) | <0.0001 | |||
| <70 | 66 (25.9) | 61 (32.3) | 5 (7.6) | |
| 70–80 | 47 (18.4) | 40 (21.2) | 7 (10.6) | |
| >80 | 142 (55.7) | 88 (46.5) | 54 (81.8) | |
| Comorbidities, n (%) | ||||
| Hypertension | 131 (51.4) | 87 (33.6) | 44 (66.4) | 0.003 |
| Diabetes | 58 (22.8) | 41 (21.7) | 17 (25.8) | 0.49 |
| Dyslipidaemias | 43 (16.9) | 30 (15.9) | 13 (19.7) | 0.56 |
| Chronic obstructive pulmonary disease | 43 (16.8) | 27 (14.3) | 16 (24.2) | 0.06 |
| Coronary heart disease | 39 (15.6) | 27 (14.4) | 12 (19.1) | 0.38 |
| Heart rhythm disorder | 45 (17.8) | 25 (13.4) | 20 (30.3) | 0.002 |
| Carcinoma | 43 (16.9) | 29 (15.4) | 14 (21.2) | 0.28 |
| Vital signs on admission, n (%) | ||||
| Hypoxia | 43 (16.9) | 25 (13.2) | 18 (27.3) | 0.008 |
| Fever | 83 (32.5) | 60 (31.7) | 23 (34.8) | 0.64 |
| Fatigue | 71 (27.8) | 59 (31.2) | 12 (18.2) | 0.05 |
| Cough | 99 (38.8) | 83 (43.9) | 16 (24.2) | 0.004 |
| Shortness of breath | 141 (55.3) | 100 (52.9) | 41 (62.2) | 0.19 |
| DP < 90 mm Hg | 232 (91.0) | 175 (92.6) | 57 (86.4) | 0.07 |
| Laboratory findings, n (%) | ||||
| White blood cell count ≥10 g/L | 48 (18.8) | 27 (14.3) | 21 (31.8) | 0.002 |
| Lymphocytes <1.5 g/L | 252 (98.8) | 187 (98.9) | 65 (98.5) | 0.76 |
| Blood platelet count <120 g/L | 30 (11.8) | 22 (11.6) | 8 (12.1) | 0.91 |
| D-dimer level >0.5 mg/mL | 45 (17.6) | 32 (16.9) | 13 (19.7) | 0.61 |
| APT time ratio >1.2 | 48 (18.8) | 25 (13.2) | 23 (34.8) | 0.0001 |
| Creatine kinase level >200 UI/L | 7 (2.8) | 3 (1.6) | 4 (6.0) | 0.07 |
| Lactate dehydrogenase level >215 UI/L | 31 (12.2) | 15 (7.9) | 16 (24.2) | 0.001 |
| ProBNP >125 ng/mL | 59 (23.1) | 36 (19.1) | 23 (34.8) | 0.008 |
| Creatininemia >10 mg/L | 102 (40.0) | 57 (30.2) | 45 (68.2) | <0.0001 |
| CRP level >50 mg/L | 130 (51.0) | 83 (43.9) | 47 (71.2) | 0.0001 |
| Hospital-acquired COVID-19 | 40 (15.7) | 22 (11.6) | 18 (27.3) | 0.002 |
COCORICO, COrsica COhorte Retrospective des Infections à Sars-COv-2; DP, diastolic pressure; APT, activated partial thromboplastin time; LDH, lactate dehydrogenase; pro-BNP, pronatriuretic peptide; CRP, C-reactive protein.